secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspira Women's Health Inc. (AWHL)
CIK:        0000926617
Form:       8-K
Filed at:   2024-01-25T23:59:59+00:00
Accession:  0001193125-24-015576
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 2.02, 3.02, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aspira Women's Health raises ~$5.5M in offering; preliminary cash $2.6M as of Dec 31, 2023
--------------------------------------------------------------------------------

- Gross proceeds of ~$5.5M from sale of 1,371,000 shares at $3.50/share plus warrants.
- CEO Nicole Sandford participated in offering; also sold 2,400 shares at $4.255/share.
- Preliminary cash and equivalents of $2.6M as of Dec 31, 2023, excluding $0.3M restricted cash.
- Existing warrants with exercise price of $13.20 amended to $4.00, expiration extended to Jan 2029.
- Offering is expected to close Jan 26, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/926617/000119312524015576/0001193125-24-015576-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/926617/000119312524015576/d699303d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-015576

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer